This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents. Top assignee: Terremoto Biosciences, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kin S Yang: Innovator in Pharmaceutical Modulation
Introduction
Kin S Yang is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of AKT1, a crucial protein involved in various cellular processes.
Latest Patents
Kin S Yang holds 2 patents that focus on innovative approaches to modulate AKT1. His latest patents include "Non-covalent modifiers of AKT1 and uses thereof," which provides non-covalent modifiers of AKT1 and pharmaceutical compositions for their application. Another significant patent is "Cysteine covalent modifiers of AKT1 and uses thereof," which explores the use of cysteine covalent modifiers in the modulation of AKT1.
Career Highlights
Kin S Yang is currently associated with Terremoto Biosciences, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic strategies that target AKT1, which has implications for various diseases.
Collaborations
He collaborates with esteemed colleagues, including Hang Chu and Solomon H Reisberg, to further enhance the impact of his research in the pharmaceutical industry.
Conclusion
Kin S Yang's innovative work in the modulation of AKT1 through his patents showcases his commitment to advancing pharmaceutical science. His contributions are expected to have a lasting impact on therapeutic development.